Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Vitamin D Deficiency 4Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Renal Insufficiency, Chronic 1Myelodysplastic Syndromes 1Multiple Sclerosis, Relapsing-Remitting 1Hepatitis B, Chronic 1Hepatitis B 1Hematologic Diseases 1Cardiovascular Diseases 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Bone Diseases, Metabolic 1Anemia, Aplastic 1Anemia 1

Interventions

Vitamin D 1Cholecalciferol 1Calcifediol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Multiple Sclerosis, Relapsing-Remitting × Cholecalciferol × Clear all
NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Tehran University of Medical Sciences

Phase 4 Unknown
54 enrolled
LymphoidOther hematologic neoplasm

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡